Home > Financial Ratios > KREBS BIOCHEMICALS & INDUSTRIES

KREBS BIOCHEMICALS & INDUSTRIES
Core EBITDA Margin

    Back to All Ratios
COMMUNITY POLL
for KREBS BIOCHEMICALS & INDUSTRIES
Please provide your vote to see the results

KREBS BIOCHEMICALS & INDUSTRIES Last 5 Year Core EBITDA Margin History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Margin(%) -34.70-17.30-30.27-56.94-32.73

What is the latest Core EBITDA Margin ratio of KREBS BIOCHEMICALS & INDUSTRIES ?

The latest Core EBITDA Margin ratio of KREBS BIOCHEMICALS & INDUSTRIES is -34.70 based on Mar2025 Standalone results.
Year Core EBITDA Margin
Mar2025-34.70
Mar2024-17.30
Mar2023-30.27
Mar2022-56.94
Mar2021-32.73

How is Core EBITDA Margin of KREBS BIOCHEMICALS & INDUSTRIES Trending?

Years Core EBITDA Margin % Change
Mar2025 -34.7
Negative
Mar2024 -17.3
Negative
Mar2023 -30.27
Negative
Mar2022 -56.94
Negative
Mar2021 -32.73 -

Other Financial Ratios of KREBS BIOCHEMICALS & INDUSTRIES


Compare Core EBITDA Margin ratio of peers of KREBS BIOCHEMICALS & INDUSTRIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
KREBS BIOCHEMICALS & INDUSTRIES ₹144.2 Cr 3.7% -4.7% -14.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹426,170.0 Cr -1.6% 4.6% -0.8% Stock Analytics
DIVIS LABORATORIES ₹167,038.0 Cr -2.5% -6% 3.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹127,357.0 Cr 1.2% -1.4% 11.8% Stock Analytics
CIPLA ₹120,414.0 Cr -1.2% -1.5% -0.1% Stock Analytics
DR REDDYS LABORATORIES ₹104,015.0 Cr -2.7% 4% 2.2% Stock Analytics


KREBS BIOCHEMICALS & INDUSTRIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
KREBS BIOCHEMICALS & INDUSTRIES

3.7%

-4.7%

-14.5%

SENSEX

-0.6%

1.7%

4.6%


You may also like the below Video Courses